ClinicalTrialsFinder

Plaque, Amyloid Clinical Trials in Houston, Texas

1 recruitingHouston, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Alzheimer DiseaseDementiaPlaque, Amyloid
Eli Lilly and Company550 enrolled58 locationsNCT07602582